Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
Safety and pharmacokinetics of motesanib in combination with gemcitabine and erlotinib for the treatment of solid tumors: a phase 1b study. [electronic resource] by
- Kotasek, Dusan
- Tebbutt, Niall
- Desai, Jayesh
- Welch, Stephen
- Siu, Lillian L
- McCoy, Sheryl
- Sun, Yu-Nien
- Johnson, Jessica
- Adewoye, Adeboye H
- Price, Timothy
Producer: 20120206
In:
BMC cancer vol. 11
Availability: No items available.
|
|
11.
|
|
|
12.
|
Differential gene expression in pulmonary artery endothelial cells exposed to sickle cell plasma. [electronic resource] by
- Klings, Elizabeth S
- Safaya, Surinder
- Adewoye, Adeboye H
- Odhiambo, Adam
- Frampton, Garrett
- Lenburg, Marc
- Gerry, Norman
- Sebastiani, Paola
- Steinberg, Martin H
- Farber, Harrison W
Producer: 20060511
In:
Physiological genomics vol. 21
Availability: No items available.
|
|
13.
|
Sickle cell leg ulcers: associations with haemolysis and SNPs in Klotho, TEK and genes of the TGF-beta/BMP pathway. [electronic resource] by
- Nolan, Vikki G
- Adewoye, Adeboye
- Baldwin, Clinton
- Wang, Ling
- Ma, Qianli
- Wyszynski, Diego F
- Farrell, John J
- Sebastiani, Paola
- Farrer, Lindsay A
- Steinberg, Martin H
Producer: 20060628
In:
British journal of haematology vol. 133
Availability: No items available.
|
|
14.
|
Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancer. [electronic resource] by
- De Boer, Richard H
- Kotasek, Dusan
- White, Shane
- Koczwara, Bogda
- Mainwaring, Paul
- Chan, Arlene
- Melara, Rebeca
- Ye, Yining
- Adewoye, Adeboye H
- Sikorski, Robert
- Kaufman, Peter A
Producer: 20130124
In:
Breast cancer research and treatment vol. 135
Availability: No items available.
|
|
15.
|
Sickle cell vaso-occlusive crisis induces the release of circulating serum heat shock protein-70. [electronic resource] by
- Adewoye, Adeboye H
- Klings, Elizabeth S
- Farber, Harrison W
- Palaima, Elizabeth
- Bausero, Maria A
- McMahon, Lillian
- Odhiambo, Adam
- Surinder, Safaya
- Yoder, Mark
- Steinberg, Martin H
- Asea, Alexzander
Producer: 20050404
In:
American journal of hematology vol. 78
Availability: No items available.
|
|
16.
|
Evaluation of the CLL-IPI in relapsed and refractory chronic lymphocytic leukemia in idelalisib phase-3 trials. [electronic resource] by
- Soumerai, Jacob D
- Ni, Ai
- Xing, Guan
- Huang, Julie
- Furman, Richard R
- Jones, Jeffrey
- Sharman, Jeffrey P
- Hallek, Michael
- Adewoye, Adeboye H
- Dubowy, Ronald
- Dreiling, Lyndah
- Zelenetz, Andrew D
Producer: 20200720
In:
Leukemia & lymphoma vol. 60
Availability: No items available.
|
|
17.
|
Final results of a phase 1b study of the safety and efficacy of the PI3Kδ inhibitor acalisib (GS-9820) in relapsed/refractory lymphoid malignancies. [electronic resource] by
- Kater, Arnon P
- Tonino, Sanne H
- Spiering, Marjolein
- Chamuleau, Martine E D
- Liu, Roberto
- Adewoye, Adeboye Henry
- Gao, Jie
- Dreiling, Lyndah
- Xin, Yan
- Doorduijn, Jeanette K
- Kersten, Marie José
Producer: 20180829
In:
Blood cancer journal vol. 8
Availability: No items available.
|
|
18.
|
A network model to predict the risk of death in sickle cell disease. [electronic resource] by
- Sebastiani, Paola
- Nolan, Vikki G
- Baldwin, Clinton T
- Abad-Grau, Maria M
- Wang, Ling
- Adewoye, Adeboye H
- McMahon, Lillian C
- Farrer, Lindsay A
- Taylor, James G
- Kato, Gregory J
- Gladwin, Mark T
- Steinberg, Martin H
Producer: 20071106
In:
Blood vol. 110
Availability: No items available.
|
|
19.
|
Estimated glomerular filtration rate in sickle cell anemia is associated with polymorphisms of bone morphogenetic protein receptor 1B. [electronic resource] by
- Nolan, Vikki G
- Ma, Qianli
- Cohen, Herbert T
- Adewoye, Adeboye
- Rybicki, Anne C
- Baldwin, Clinton
- Mahabir, Rhea N
- Homan, Erica P
- Wyszynski, Diego F
- Fabry, Mary E
- Nagel, Ronald L
- Farrer, Lindsay A
- Steinberg, Martin H
Producer: 20070412
In:
American journal of hematology vol. 82
Availability: No items available.
|
|
20.
|
Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trial. [electronic resource] by
- Zelenetz, Andrew D
- Barrientos, Jacqueline C
- Brown, Jennifer R
- Coiffier, Bertrand
- Delgado, Julio
- Egyed, Miklós
- Ghia, Paolo
- Illés, Árpád
- Jurczak, Wojciech
- Marlton, Paula
- Montillo, Marco
- Morschhauser, Franck
- Pristupa, Alexander S
- Robak, Tadeusz
- Sharman, Jeff P
- Simpson, David
- Smolej, Lukáš
- Tausch, Eugen
- Adewoye, Adeboye H
- Dreiling, Lyndah K
- Kim, Yeonhee
- Stilgenbauer, Stephan
- Hillmen, Peter
Producer: 20170608
In:
The Lancet. Oncology vol. 18
Availability: No items available.
|